April 15, 2009
Neosalus Cream approved for dermatitisQuinnova Pharmaceuticals' Neosalus Cream, a prescription non-steroidal anti-inflammatory topical cream, has been FDA approved for the treatment of various types of dermatoses, including atopic dermatitis and hand eczema. Neosalus Cream is a non-greasy, water-lipid based formulation which utilizes Quinnova's Proderm Technology to provide skin barrier repair, protection, and moisturization. Neosalus Cream replenishes physiological lipids to decrease trans-epidermal water loss and acts as a protectant against irritants. Its anti-inflammatory ability helps to reduce the frequency and severity of flare-ups, thus making it a steroid sparing and complementary treatment to other concomitant treatments.
For more information call (215) 860-6263 or visit www.quinnova.com.